NT-proBNP as a Diagnostic Marker in CCF

Dr. Vedavathi R.

Authors

Dr. Vedavathi R.

Keywords:

Abstract

Abstract not found

Downloads

How to Cite

NT-proBNP as a Diagnostic Marker in CCF. (2016). Global Journal of Medical Research, 16(37), 51-56. https://medicalresearchjournal.org/index.php/GJMR/article/view/

Download Citation

References

Schocken DD, Benjamin EJ, Fonarrow GC (2008) Prevention of heart failure: A scientific statement from the American heart association councils on Epidemiology and prevention, Clinical Cardiology, Cardiovascular Nursing, and high blood pressure Research; Quality care and Outcomes Research Interdisciplinary Working group; and Functional Genomics and Translational Biology Interdisciplinary Working Group. 117, 2544.

D. Mann, L. Chakinala, M. McGraw-Hill, ;. Longo, D. Fauci, A. Kasper, D. Hauser, S. Heart Failure: Pathophysiology and diagnosis. 1.

Yancy CW, Jessup M, Bozkurt B, ButlerJ, Casey DE, Drazner M (2013) ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/ American Heart Association Task Forcw on Practice guidelines. 128, 240-327.

Jjv McMurray, S. Adamopoulos, S. Anker, A. Auricchio, M. Bohm, K. Dickstein (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European society of cardiology. Developed in collaboration with the heart failure association (HFA) of the ESC. 14, 803-869.

Dokainish H (2007) Combining tissue Doppler Echocardiography and B-type natriuretic peptide in the evaluation of left ventricular filling pressures: review of literature and clinical recommendations. 23, 983-9.